bioRxiv Science⌕ Search

Biology subjects

Zundler, S.

Publications and source records attributed to Zundler, S..

2 recordsLinked to original sources

Csf1r-mediated depletion of midbrain microglia prevents dopaminergic neuron loss during chronic colitis

Inflammatory bowel disease (IBD) predisposes to neuropsychiatric comorbidity and particularly increases the risk of Parkinsons Disease (PD) in later life. Although the gut-immune-brain axis was proposed as a link between IBD and PD and a driver of PD immunopathogenesis, the regional pattern and single-cell landscape of the brain immune response during colitis and its contribution to PD pathology remain poorly defined. Here, we observe a loss of dopaminergic neurons in the substantia nigra pars compacta of adult mice with chronic colitis. By confocal microscopy and integrated multi-omics, we reveal a complex midbrain-centered immune response to chronic colitis in comparison to the cortex, hippocampus, and striatum. Single-cell mapping of the midbrain immune landscape showed an inflammatory shift of microglial clusters including an expansion of interferon-response microglia, CD8+ T cell extravasation, and increased numbers of vessel-associated neutrophils. Selective myeloid cell depletion using a colony stimulating factor 1 receptor (Csf1r) inhibitor after colitis onset reduced midbrain microglia by 67% and led to a complete rescue of dopaminergic neuron loss, without affecting mucosal pathology or T cell and neutrophil migration to the midbrain. Collectively, within the complex innate and adaptive midbrain immune response to chronic colitis, we demonstrate a causal role of Csf1r-dependent microglia for dopaminergic neurodegeneration. Thus, Csf1r inhibition in IBD may not locally ameliorate colitis, but provide neuroprotection to dopaminergic neurons. These results reveal a novel cellular link between chronic gut-derived peripheral inflammation and midbrain vulnerability and thereby substantially enhance our understanding of the risk for PD related to the gut-immune-brain axis. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=174 SRC="FIGDIR/small/700559v1_ufig1.gif" ALT="Figure 1"> View larger version (58K): org.highwire.dtl.DTLVardef@1bf7217org.highwire.dtl.DTLVardef@1db66c0org.highwire.dtl.DTLVardef@136ef2eorg.highwire.dtl.DTLVardef@190f641_HPS_FORMAT_FIGEXP M_FIG Graphical abstract. C_FIG

neuroscience↗

Single-cell dissection of urine-derived stem cell hierarchies reveals robust chondrogenesis and clinical scalability

Developing of models of human cartilage and bone growth is essential for the study of growth disorders and to advance towards personalized therapeutic interventions. The majority of in vitro strategies depend on the use of invasively obtained mesenchymal stem cells (MSCs) or the laborious generation of induced pluripotent stem cells (iPSCs). We have now established urine-derived stem cells (USCs) as a non-invasive stem cell source capable of osteogenic and robust chondrogenic spheroid differentiation. Single-cell RNA sequencing of USCs revealed a hierarchy originating from parietal epithelial cells of the kidney, with a proliferative TOP2A subpopulation governed by MYC and E2F4 regulatory networks. Pseudo-time analysis of chondrogenic USCs uncovered alternative chondrogenic differentiation trajectories with an ALDH1A2 intermediate state and a TIMP3-expressing chondrocyte-like subpopulation as the major endpoint, exhibiting cartilage-specific gene ontologies. In conclusion, a streamlined, xeno-free culture and differentiation protocol was developed, thereby establishing the basis for clinical-grade cell expansion and cartilage matrix formation. This positions USCs as a powerful tool for studying cartilage biology and a potential platform for development and use in regenerative therapies.

genetics↗